| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 6e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |